MECHANICAL PUMP FOR TYPE 2 DIABETICS

Link

Very interesting @Carlos71, as in English, I have translated it (automatically) and copy here.

v-ste of insulin administration devices for the effective 2s type in management glycemia levels

The V-G-GO Diserable Insulin Administration Device continues to demonstrate its effectiveness in blood sugar control in people with type 2 diabetes, according to a recent study published in Endocrine Practice, the magazine reviewed by official pairs of the American Associationof clinical endocrinologists (AACE).

Considered as the first of its class in supporting insulin needs in patients with type 2 diabetes, V-GO offers insulin through basal doses ('throughout the day, pre-programmed doses that are deliveredhour the fulfillment of its "background" dose of insulin), and the doses in insulin bolus (insulin with meals).

While the V-GO insulin delivery system is programmed in a way that is very similar to an insulin pump but is not really considered an insulin pump and is specifically designed for the unique needs of people with type 2 diabetes.

Early success with the insulin administration device V-GO
In the spring of 2015, an evaluation study of 150 patients who were struggling to handle their sugar levels in a traditional insulin dosing regime were placed in the V-GO system.

"The patients were either in previously in multiple daily injections of insulin (MDI), of prolonged action with basal insulin (basal) therapy, or were naive to insulin at the beginning of the study (naïve). Monitoring data for each visit were collected for each visit for each visitlater, where a value of A1C was recorded, "explained the press release in May 2015."

In addition, the total number of insulin patients necessary was significantly reduced during the use of V-G.

New success with the insulin administration device V-GO
More recently, while the V-GO continues to demonstrate the effectiveness in the management of blood sugar levels, now the results of A1C are being successfully reduced and demonstrate to be more profitable, also.

"The addition of insulin of action to intensify insulin therapy is often the next step when patients do not reach glycemic objectives with basal insulin regimes. V-G-GO offers bolus-base coverage, and their efficacy has been demonstratedIn previous studies;(MDI) In patients with properly controlled type 2 diabetes with basal insulin regimes, "said Dr. Lajara, a research team member.

The results demonstrate a significant decrease in A1C for both insulin administration methods at the following 12 and 27 weeks insulin intensification.

"The monthly cost of inferential direct pharmacy," explains the report, "associated with the reduction of A1c 1% with V-GO was significantly lower than the MDI (multiple daily injections)."

The month of using V-GO was $ 118.84 compared to $ 217.16, almost a difference of $ 100.

"Diabetes is a progressive disease that translates into the need for intensive insulin treatment for most patients over time. Consideration of new insulin administration methods is justified when clinical and economic benefits can be performed byPatients, doctors and health plans.In this study, V-GO was beneficial if compared to the multiple doses as a method to deliver intensifies insulin therapy, "concluded Dr. Davidson, another member of the research team.

About insulin Disposable Delivery Device
"V-GO is a small, discreet, laptop and easy to use insulin administration solution for the administration of basal-bolus-bolus therapy in adults with type 2 diabetes. V-G-scatches allows patients to imitate the patternNormal physiological of the insulin administration body by releaseing a single type of insulin at a continuous pre -established basal rate for a 24 -hour period and also provides a bolus dosage on demand on meals, "explains Valeritas.

"V-log is mechanical and use 24 hours without electronics, batteries, infusion or programming equipment., with approximately an ounce when it is filled with insulin.

Taking into account the use of V-GO for your own diabetes management?Talk to your medical care team and insurance to start the process.

ADDITIONAL BIBLIOGRAPHY ON V-GO OF INSULIN ADMINISTRATION DEVICES:

The story of a patient: use of the v-scim insulin device for type 2 diabetes
The improvement of A1C with the V-GO insulin system for type 2 diabetes
Insulin device V-G for type 2 diabetes

Very interesting @Carlos71, as in English, I have translated it (automatically) and copy here.

v-ste of insulin administration devices for the effective 2s type in management glycemia levels

The V-G-GO Diserable Insulin Administration Device continues to demonstrate its effectiveness in blood sugar control in people with type 2 diabetes, according to a recent study published in Endocrine Practice, the magazine reviewed by official pairs of the American Associationof clinical endocrinologists (AACE).

Considered as the first of its class in supporting insulin needs in patients with type 2 diabetes, V-GO offers insulin through basal doses ('throughout the day, pre-programmed doses that are deliveredhour the fulfillment of its "background" dose of insulin), and the doses in insulin bolus (insulin with meals).

While the V-GO insulin delivery system is programmed in a way that is very similar to an insulin pump but is not really considered an insulin pump and is specifically designed for the unique needs of people with type 2 diabetes.

Early success with the insulin administration device V-GO
In the spring of 2015, an evaluation study of 150 patients who were struggling to handle their sugar levels in a traditional insulin dosing regime were placed in the V-GO system.

"The patients were either in previously in multiple daily injections of insulin (MDI), of prolonged action with basal insulin (basal) therapy, or were naive to insulin at the beginning of the study (naïve). Monitoring data for each visit were collected for each visit for each visitlater, where a value of A1C was recorded, "explained the press release in May 2015."

In addition, the total number of insulin patients necessary was significantly reduced during the use of V-G.

New success with the insulin administration device V-GO
More recently, while the V-GO continues to demonstrate the effectiveness in the management of blood sugar levels, now the results of A1C are being successfully reduced and demonstrate to be more profitable, also.

"The addition of insulin of action to intensify insulin therapy is often the next step when patients do not reach glycemic objectives with basal insulin regimes. V-G-GO offers bolus-base coverage, and their efficacy has been demonstratedIn previous studies;(MDI) In patients with properly controlled type 2 diabetes with basal insulin regimes, "said Dr. Lajara, a research team member.

The results demonstrate a significant decrease in A1C for both insulin administration methods at the following 12 and 27 weeks insulin intensification.

"The monthly cost of inferential direct pharmacy," explains the report, "associated with the reduction of A1c 1% with V-GO was significantly lower than the MDI (multiple daily injections)."

The month of using V-GO was $ 118.84 compared to $ 217.16, almost a difference of $ 100.

"Diabetes is a progressive disease that translates into the need for intensive insulin treatment for most patients over time. Consideration of new insulin administration methods is justified when clinical and economic benefits can be performed byPatients, doctors and health plans.In this study, V-GO was beneficial if compared to the multiple doses as a method to deliver intensifies insulin therapy, "concluded Dr. Davidson, another member of the research team.

About insulin Disposable Delivery Device
"V-GO is a small, discreet, laptop and easy to use insulin administration solution for the administration of basal-bolus-bolus therapy in adults with type 2 diabetes. V-G-scatches allows patients to imitate the patternNormal physiological of the insulin administration body by releaseing a single type of insulin at a continuous pre -established basal rate for a 24 -hour period and also provides a bolus dosage on demand on meals, "explains Valeritas.

"V-log is mechanical and use 24 hours without electronics, batteries, infusion or programming equipment., with approximately an ounce when it is filled with insulin.

Taking into account the use of V-GO for your own diabetes management?Talk to your medical care team and insurance to start the process.

ADDITIONAL BIBLIOGRAPHY ON V-GO OF INSULIN ADMINISTRATION DEVICES:

The story of a patient: use of the v-scim insulin device for type 2 diabetes
The improvement of A1C with the V-GO insulin system for type 2 diabetes
Insulin device V-G for type 2 diabetes